Sido Muncul PT - Asset Resilience Ratio
Sido Muncul PT (SIDO) has an Asset Resilience Ratio of 6.15% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Sido Muncul PT (SIDO) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2024)
This chart shows how Sido Muncul PT's Asset Resilience Ratio has changed over time. See net assets of Sido Muncul PT for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Sido Muncul PT's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see SIDO stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp230.24 Billion | 6.15% |
| Short-term Investments | Rp0.00 | 0% |
| Total Liquid Assets | Rp230.24 Billion | 6.15% |
Asset Resilience Insights
- Limited Liquidity: Sido Muncul PT maintains only 6.15% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Sido Muncul PT Industry Peers by Asset Resilience Ratio
Compare Sido Muncul PT's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Daihan Pharmaceutical Co.Ltd
KQ:023910 |
Drug Manufacturers - Specialty & Generic | 11.95% |
|
Aurobindo Pharma Limited
NSE:AUROPHARMA |
Drug Manufacturers - Specialty & Generic | 16.92% |
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999 |
Drug Manufacturers - Specialty & Generic | 5.22% |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538 |
Drug Manufacturers - Specialty & Generic | 2.69% |
|
Zhejiang Xianju Pharmaceutical Co Ltd
SHE:002332 |
Drug Manufacturers - Specialty & Generic | 6.02% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Hainan Honz Pharmaceutical Co
SHE:300086 |
Drug Manufacturers - Specialty & Generic | 0.27% |
|
Guangdong Lifestrong Pharmacy Co. Ltd.
SHE:301111 |
Drug Manufacturers - Specialty & Generic | 7.85% |
Annual Asset Resilience Ratio for Sido Muncul PT (2013–2024)
The table below shows the annual Asset Resilience Ratio data for Sido Muncul PT.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 9.75% | Rp384.24 Billion ≈ $22.51 Million |
Rp3.94 Trillion ≈ $230.85 Million |
-5.18pp |
| 2023-12-31 | 14.93% | Rp580.86 Billion ≈ $34.04 Million |
Rp3.89 Trillion ≈ $227.98 Million |
-20.40pp |
| 2022-12-31 | 35.33% | Rp1.44 Trillion ≈ $84.49 Million |
Rp4.08 Trillion ≈ $239.16 Million |
-6.25pp |
| 2021-12-31 | 41.58% | Rp1.69 Trillion ≈ $99.13 Million |
Rp4.07 Trillion ≈ $238.43 Million |
+7.37pp |
| 2020-12-31 | 34.20% | Rp1.32 Trillion ≈ $77.15 Million |
Rp3.85 Trillion ≈ $225.57 Million |
+12.00pp |
| 2019-12-31 | 22.21% | Rp785.38 Billion ≈ $46.02 Million |
Rp3.54 Trillion ≈ $207.25 Million |
+2.00pp |
| 2018-12-31 | 20.21% | Rp674.45 Billion ≈ $39.52 Million |
Rp3.34 Trillion ≈ $195.57 Million |
-3.83pp |
| 2017-12-31 | 24.03% | Rp759.00 Billion ≈ $44.47 Million |
Rp3.16 Trillion ≈ $185.06 Million |
+23.87pp |
| 2016-12-31 | 0.17% | Rp5.00 Billion ≈ $292.98K |
Rp2.99 Trillion ≈ $175.06 Million |
-6.63pp |
| 2015-12-31 | 6.80% | Rp190.00 Billion ≈ $11.13 Million |
Rp2.80 Trillion ≈ $163.84 Million |
-7.03pp |
| 2014-12-31 | 13.82% | Rp390.00 Billion ≈ $22.85 Million |
Rp2.82 Trillion ≈ $165.32 Million |
+4.95pp |
| 2013-12-31 | 8.87% | Rp261.82 Billion ≈ $15.34 Million |
Rp2.95 Trillion ≈ $172.95 Million |
-- |
About Sido Muncul PT
PT Industri Jamu dan Farmasi Sido Muncul Tbk provides herbal medicines, cosmetics, and foods and beverage products in Indonesia. The company operates through three segments: Herbal Medicine and Supplements; Food and Beverage; and Pharmacy. It also offers medicine products comprising ethical/prescriptions and OTCs; herbal products, such as traditional herbals, food and beverages, herbal medicines,… Read more